Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$0.60 USD
-0.01 (-1.52%)
Updated May 31, 2024 04:00 PM ET
After-Market: $0.60 0.00 (0.70%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
APDN 0.60 -0.01(-1.52%)
Will APDN be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for APDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APDN
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
Clear Secure (YOU) Q1 Earnings and Revenues Top Estimates
APDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Automation (ROK) Q2 Earnings and Revenues Surpass Estimates
Allegion (ALLE) Q1 Earnings Surpass Estimates
Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?
Other News for APDN
Applied DNA Sciences’ $12M Securities Offering and Agreement
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
Dow Dips Over 100 Points; GameStop Shares Spike higher
Applied DNA stock plunges after pricing $12M securities offering